Itron, Inc. (NASDAQ:ITRI) Receives $131.22 Consensus Price Target from Analysts

Itron, Inc. (NASDAQ:ITRIGet Free Report) has been given an average rating of “Hold” by the thirteen brokerages that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $131.2222.

ITRI has been the topic of several recent analyst reports. Oppenheimer upped their price objective on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a report on Thursday, April 16th. Zacks Research downgraded Itron from a “hold” rating to a “strong sell” rating in a report on Friday, July 17th. Raymond James Financial began coverage on Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating for the company. TD Cowen reduced their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Itron in a research report on Friday, May 8th.

Get Our Latest Stock Report on ITRI

Itron Price Performance

ITRI stock opened at $84.22 on Friday. The firm has a market cap of $3.73 billion, a PE ratio of 13.43, a PEG ratio of 0.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66. The firm’s 50 day moving average price is $82.96 and its 200-day moving average price is $89.82. Itron has a one year low of $77.77 and a one year high of $142.00.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The firm’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, equities research analysts anticipate that Itron will post 6.01 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Donald L. Reeves III sold 319 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the sale, the senior vice president owned 29,100 shares of the company’s stock, valued at approximately $2,455,167. This represents a 1.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of Itron stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the completion of the transaction, the senior vice president owned 24,689 shares of the company’s stock, valued at approximately $2,083,010.93. This trade represents a 1.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 3,946 shares of company stock worth $324,420 over the last 90 days. Corporate insiders own 1.77% of the company’s stock.

Institutional Investors Weigh In On Itron

A number of large investors have recently modified their holdings of the company. Dimensional Fund Advisors LP increased its holdings in Itron by 20.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock valued at $137,659,000 after buying an additional 265,039 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Itron by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock valued at $106,340,000 after purchasing an additional 6,598 shares in the last quarter. First Trust Advisors LP increased its stake in Itron by 22.2% in the first quarter. First Trust Advisors LP now owns 969,228 shares of the scientific and technical instruments company’s stock valued at $86,872,000 after purchasing an additional 176,053 shares during the last quarter. Norges Bank purchased a new position in Itron in the fourth quarter valued at approximately $63,990,000. Finally, Arrowstreet Capital Limited Partnership raised its holdings in Itron by 12.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock worth $60,359,000 after purchasing an additional 73,020 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

See Also

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.